About Pirouette Pharma
Pirouette Pharma is a private company based in Portsmouth, New Hampshire. It has reported $13,955,537 raised in five offerings on Form D since July 2021. Its chief executive is Conor Cullinane.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 18, 2026 | $1,080,537of $6.0M target | 1 | $1.0M | Equity, Options, Securities on exercise, Simple Agreement for Future EquityRule 506(c) | Form D ↗ |
| Mar 28, 2025 | Apr 1, 2025 | $2,350,000of $3.5M target | 1 | $2.3M | Equity, Options, Securities on exercise, Simple Agreement for Future EquityRule 506(c) | Form D ↗ |
| May 31, 2022 | Jun 15, 2022 | $2,550,000of $15.0M target | 2 | $1.2M | Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Aug 19, 2021 | Sep 2, 2021 | $6,950,000of $10.5M target | 29 | $239K | EquityRule 506(b) | Form D ↗ |
| Jun 21, 2021 | Jul 6, 2021 | $1,025,000of $1.2M target | 8 | $128K | Options, Securities on exercise, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $13,955,537 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pirouette Pharma's Form D filed Mar 18, 2026.
Earlier filings also listed Arunas Chesonis (executive officer, director and promoter, last listed Sep 2021).
Sources
- SECPIROUETTE PHARMA INC. filing history
- CompanyContact
- CompanyLeadership team